Schedule 13D ownership disclosure

RTI Biologics, Inc.

Security class unavailable · CUSIP: 74975N105

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,530,645
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001609251-17-000005
Form type
SC 13D/A
Filer
Krensavage Asset Management, LLC
CIK
CIK 1609251
Filed
Feb 17, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub